在西班牙患有生长激素缺乏症的儿科患者群体中,索马特龙的成本效益
M A Andreu Crespo1, L Castro-Feijóo2, J I Labarta-Aizpún3
1Pharmacy Department, Hospital Germans Trias i Pujol, Badalona, Spain.
Expert review of pharmacoeconomics & outcomes research
|September 24, 2023
概括
与每日生长激素 (GH-d) 相比,每周索马特龙是西班牙儿科生长激素缺乏症 (GHD) 的经济有效治疗方法. 它提供了显著的质量调整寿命年 (QALY) 收益,使其成为主要的治疗选择.
科学领域:
- 药物经济学 药物经济学
- 儿科内分泌学 儿科内分泌学
- 卫生技术评估 卫生技术评估
背景情况:
- 生长激素缺乏 (GHD) 影响儿童的生长和发育.
- 每日生长激素 (GH-d) 是一种标准的治疗方法,但坚持和管理可能具有挑战性.
- 新的治疗选择,如每周服用索马特龙,旨在改善患者的治疗结果和方便性.
研究的目的:
- 在西班牙患有GHD的儿童中,评估每周索马特龙与每日生长激素 (GH-d) 的成本效益.
- 从西班牙国家卫生系统的角度评估索马特龙的经济价值.
主要方法:
- 使用马尔科夫模型来模拟患有GHD的青春期前儿童的治疗结果.
- 该模型包含了来自西班牙来源的激素和监测成本,以及来自现有文献的公用事业.
- 西班牙临床专家验证了假设,模拟延伸到18岁.
主要成果:
- 确定性分析表明,索马特龙具有成本效益,每QALY的成本为19,259欧元,QALY的收益为0.336欧元.
- 概率分析显示,索马特龙是主要的治疗方法,在每QALY支付25,000欧元的意愿下,其概率为61%.
结论:
- 在西班牙,每周索马特龙为儿科GHD提供了每日生长激素 (GH-d) 的经济有效替代品.
- 索马特龙显示出有利的经济和临床价值,支持其在这个人群中的使用.
相关概念视频
Glucagon-like Receptor Agonists
348
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
348
Prescription, Nonprescription and Orphan Drugs
756
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
756
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
191
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
191


